Previous Myocardial Injury Tied to Worse COVID-19 Outcomes
Significant but weaker associations with selected adverse outcomes seen for preexisting hypertension, diabetes, and ischemic heart disease
Cardiovascular Disease
FDA to Review Wearable Furosemide Delivery System for Outpatient Use
Furoscix is a wearable, pre-programmed on-body furosemide delivery system for outpatient self-administration.
Erectile Dysfunction Ups Risk for Major Adverse Cardiovascular Events
Investigators urge health care professionals who manage patients with ED to discuss the risk of future cardiovascular disease.
Dapagliflozin Reduces CV Death, Heart Failure Worsening in HFpEF Patients
The placebo-controlled, event-driven DELIVER study included 6263 patients.
Therapies to Slow Vascular Calcification in CKD Explored
Promising therapies still need to be further evaluated in clinical trials.
USPSTF: Do Not Start Low-Dose Aspirin to Prevent CVD in 60+
For those aged 40 to 59 years, the decision to initiate low-dose aspirin for primary prevention of CVD should be individualized
PDE5 Inhibitors Prescribed for Men on Oral Nitrates for IHD
Among men with ischemic heart disease, coprescription of nitrates and PDE5 inhibitors not linked to increased risk for cardiovascular events
Apixaban Tied to Lower Risk for Recurrent VTE in Dialysis Population
Apixaban is a direct oral anticoagulant that relies less on kidney excretion.
Cardiovascular Disease, Mortality Higher With Serious Mental Illness
Association stronger in most recent decades and among those with schizophrenia
Cardiovascular Mortality Decreasing in the Dialysis Population
Although cardiovascular mortality rates declined, clinicians should still be vigilant to prevent poor outcomes in patients receiving dialysis, according to investigators.
- Loading...
Loading...
Next post in Cardiovascular Disease (CVD)
Loading... 
Loading...